The role of resection for melanoma metastases to the pancreas

Guerra, Francesco; Coletta, Diego; Deutsch, Gary B.; Giuliani, Giuseppe; Patriti, Alberto; Fischer, Trevan; Coratti, Andrea; Serafini, Simone; Surjan, Rodrigo C.; Milanetto, Anna Caterina; Campra, D

doi:10.1016/j.hpb.2022.08.012

Search citation statements

Order By: Relevance

Paper Sections

Select...

Malignant Melanoma1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, for solitary pancreatic metastases, the 1-year, 3-year, and 5-year survival rates were 76%, 43%, and 41%, respectively. The authors concluded that curative pancreatic resection may positively influence survival in selected patients [112].…”

Section: Malignant Melanomamentioning

confidence: 99%

Comments on and Illustrations of the EFSUMB CEUS Guidelines: Transabdominal and Endoscopic Ultrasound Features of Intrapancreatic Metastases and the Role of Multiparametric Imaging and EUS-Guided Sampling in Rare Pancreatic Tumors

Möller

Jenssen

Braden

et al. 2023

Cancers

View full text Add to dashboard Cite

A definite pathologic diagnosis of intrapancreatic metastasis is crucial for the management decision, i.e., curative or palliative surgery versus chemotherapy or conservative/palliative therapy. This review focuses on the appearance of intrapancreatic metastases on native and contrast-enhanced transabdominal ultrasound and endoscopic ultrasound. Differences and similarities in relation to the primary tumor, and the differential diagnosis from pancreatic carcinoma and neuroendocrine neoplasms are described. The frequency of intrapancreatic metastases in autopsy studies and surgical resection studies will be discussed. Further emphasis is placed on endoscopic ultrasound-guided sampling to confirm the diagnosis.

show abstract

Section: Malignant Melanomamentioning

confidence: 99%